Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
All content for UKMFA is the property of Ian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
Dr Teck Khong on Ethical Considerations in Medical Practice & Politics
UKMFA
58 minutes
11 months ago
Dr Teck Khong on Ethical Considerations in Medical Practice & Politics
Disclaimer: https://rumble.com/v6056un-ukmfa-disclaimer.html In this conversation, Ian Humphreys and Dr Teck Khong, leader of the Alliance for Democracy & Freedom Party, discuss the current political landscape, focusing on the challenges and opportunities within political alliances, the need for strong leadership, and the importance of effective activism. They explore the role of local councils in health policy, the evolution of general practice, and the ethical considerations in medical ...
UKMFA
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...